scholarly journals Valproic acid-induced acute pancreatitis

2019 ◽  
Vol 61 (4) ◽  
pp. 421 ◽  
Author(s):  
Vandana Roy ◽  
Ayush Jain ◽  
Ijasul Haque ◽  
Vandana Tayal
2021 ◽  
Vol 13 (1) ◽  
pp. 98-103
Author(s):  
Agnieszka Pawłowska-Kamieniak ◽  
Paulina Krawiec ◽  
Elżbieta Pac-Kożuchowska

Acute pancreatitis (AP) appears to be rare disease in childhood. In children, it has a different aetiology and course, and requires different management than in adult patients. The diagnosis of AP is based on at least two of the three criteria, which include typical clinical symptoms, abnormalities in laboratory tests and/or imaging studies of the pancreas. There are many known causes leading to AP in children including infections, blunt abdominal trauma, genetic factors, gallstone disease, metabolic disorders, anatomical defects of the pancreas, systemic diseases, as well as drugs, including antiepileptic drugs, and especially preparations of valproic acid. In our study, we present four cases of young patients diagnosed with acute pancreatitis as a complication of valproic acid therapy and we present a review of the literature. We believe that the activity of pancreatic enzymes should be monitored in children treated with valproate preparations in the case of clinical symptoms suggesting AP.


2001 ◽  
Vol 15 (2) ◽  
pp. 127-130 ◽  
Author(s):  
Mary Anne Cooper ◽  
Aubrey Groll

A 14-year-old child treated with valproic acid over several years for a seizure disorder developed abdominal pain with radiological evidence of acute pancreatitis. The association with valproic acid was not recognized, and the child continued to take the drug. The patient eventually developed steatorrhea and weight loss that improved with pancreatic enzyme replacement. Radiological evaluation showed an atrophic pancreas. Without evidence of other etiological factors, valproic acid by itself appeared to be the cause of chronic pancreatitis with exocrine pancreatic insufficiency in this patient.


2006 ◽  
Vol 13 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Mette N??rgaard ◽  
Jacob Jacobsen ◽  
Chaveewan Ratanajamit ◽  
Peter Jepsen ◽  
Joseph K. McLaughlin ◽  
...  

2003 ◽  
Vol 28 (2) ◽  
pp. 145-148 ◽  
Author(s):  
Nancy L Grauso-Eby ◽  
Olga Goldfarb ◽  
Lori B Feldman-Winter ◽  
Gary N McAbee

2009 ◽  
Vol 67 (2b) ◽  
pp. 513-515 ◽  
Author(s):  
José Guevara-Campos ◽  
Lucía González-Guevara ◽  
Ixora Vacaro-Bolívar ◽  
Juan Manuel Rojas

1994 ◽  
Vol 27 (1) ◽  
pp. 53-57 ◽  
Author(s):  
Toshiyuki Kamijo ◽  
Toshikazu Sato ◽  
Ryozo Yanagizawa ◽  
Hiroichi Kishi

1999 ◽  
Vol 19 (5) ◽  
pp. 483-484 ◽  
Author(s):  
Suzanne E. Fecik ◽  
Steven C. Stoner ◽  
Jose Raphael ◽  
Cameron Lindsey

PEDIATRICS ◽  
1979 ◽  
Vol 64 (4) ◽  
pp. 520-522
Author(s):  
Paul B. Batalden ◽  
Bruce J. Van Dyne ◽  
James Cloyd

The development of acute pancreatitis in an 8-year-old boy being treated with valproic acid for simple absence spells is documented. A brief discussion of the other previously reported complications with valproic acid is included.


Medicina ◽  
2013 ◽  
Vol 49 (11) ◽  
pp. 76 ◽  
Author(s):  
Kadi Veri ◽  
Oivi Uibo ◽  
Inga Talvik ◽  
Tiina Talvik

Drug-induced acute pancreatitis is a rare condition in childhood, and information about the incidence of valproic acid-induced acute pancreatitis in the pediatric population is scarce. In this clinical case, we report a first documented pediatric case of valproic acid-induced pancreatitis in Estonia. A 15-year-old boy with juvenile myoclonic epilepsy developed acute pancreatitis after 2-month therapy with valproic acid. The symptoms of pancreatitis subsided within 1 week after the discontinuation of treatment with valproic acid. Acute pancreatitis should be suspected in any pedi- atric patient with gastrointestinal symptoms during valproate treatment


Cureus ◽  
2015 ◽  
Author(s):  
Sukanta Ray ◽  
Sujan Khamrui ◽  
Mohnish Kataria ◽  
Jayanta Biswas ◽  
Suman Saha

Sign in / Sign up

Export Citation Format

Share Document